familial Mediterranean fever (FMF, recurrent polyserositis)

From Aaushi
Jump to navigation Jump to search

Introduction

Recurrent systemic inflammatory disorder.

Etiology

mutation in pyrin gene

Epidemiology

(prevalence in parenthesis)

  • ethnic groups from the easterm Mediterranean basin
    • Sephardic Jewish (0.1-0.4%)
    • Ashkenazi Jewish (0.001%)
    • Armenian (0.2%)
    • Arabs (0.1%)
    • Turkish (0.04%)
  • male:female ratio is 1.5-2.0: 1
  • generally presents during childhood or adolescence
    • 65% < 10 years of age
    • 90% < 20 years of age

Pathology

Genetics

Clinical manifestations

Laboratory

Radiology

non-specifc findings

Complications

* excluding nonmelanoma skin cancer

Differential diagnosis

Management

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 1.4 Medical Knowledge Self Assessment Program (MKSAP) 11,14,16,17,18. American College of Physicians, Philadelphia 1998,2006,2012,2015,2018.
  2. Ben-Cherit E, Levy M Familial Mediterranean fever. Lancet 351:659, 1998 PMID: https://www.ncbi.nlm.nih.gov/pubmed/9500348
  3. Levneh A et al, Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879, 1997 PMID: https://www.ncbi.nlm.nih.gov/pubmed/9336425
  4. 4.0 4.1 Tunca M, Ben-Chetrit E Familial Mediterranean fever in 2003. Pathogenesis and management.. Clin Exp Rheumatol 21:S53, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14727461
  5. 5.0 5.1 Atagunduz P et al, MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement. Exp Rheumatol 21:S35, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14727457
  6. Mor A et al, Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterol 98:2594, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14687803
  7. 7.0 7.1 Gershoni-Baruch R et al, Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schonlein purpura. J Pediatr 143:658, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14615741
  8. 8.0 8.1 Touitou I, Standardized testing for mutations in familial Mediterranean fever. Clin Chem 49:1781, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14578308
    Oberkanins C et al, Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips. Clin Chem. 2003 Nov;49(11):1948-50 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14578333
    Tchernitchko D et al, Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. Clin Chem 49:1942, 2003 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/14578331
  9. <Internet> http://www.emedicine.com/med/topic1410.htm has an excellent discussion
  10. Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009 Oct 15;61(10):1447-53 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19790133
  11. 11.0 11.1 Brenner R, Ben-Zvi I, Shinar Y et al. Familial Mediterranean fever and incidence of cancer. Arthritis Rheumatol 2018 Jan; 70:127 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28992365 <Internet> http://onlinelibrary.wiley.com/doi/10.1002/art.40344/abstract
  12. 12.0 12.1 De Benedetti F, Gattorno M, Anton J et al Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. N Engl J Med 2018; 378:1908-1919. May 17, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29768139 https://www.nejm.org/doi/full/10.1056/NEJMoa1706314
  13. 13.0 13.1 13.2 13.3 NEJM Knowledge+ Complex Medical Care
  14. Mediterranean fever, familial http://ghr.nlm.nih.gov/condition=mediterraneanfeverfamilial

Patient information

familial Mediterranean fever patient information

Database